LB Pharmaceuticals Stock (NASDAQ:LBRX)
Previous Close
$19.70
52W Range
$13.36 - $23.15
50D Avg
$17.02
200D Avg
$16.65
Market Cap
$533.07M
Avg Vol (3M)
$182.19K
Beta
-
Div Yield
-
LBRX Company Profile
Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.